Altimmune, Inc. (ALT) Tops Q2 EPS by 4c

Altimmune, Inc. (NASDAQ: ALT) reported Q2 EPS of ($0.27), $0.04 better than the analyst estimate of ($0.31).

For earnings history and earnings-related data on Altimmune, Inc. (ALT) click here.

You May Also Be Interested In

• Corning (GLW) files for up to $2B offering of common shares
• Goldman, BofA vie to manage Anthropic employee wealth post-IPO - report
• Micron offers Taiwan workers up to 68-month bonuses as strike threat looms